At the time of writing, Weebit Nano Ltd. has a market capitalisation of AUD$34m.
When it started trading in August 2016, it was worth more than double its current price.
Weebit is one of several companies developing a ReRAM cell, that can be used to create a memory chip with a combination of speed, reliability and size, that is very different and an improvement, on existing chip technology.
Plus, in the Weebit case, it uses fabrication materials currently used by chip makers, making it theoretically quicker to shift into production.
"Will be very attractive for companies using leading-edge designs, including leading Artificial Intelligence and Internet of Things applications” said CEO, Coby Hanoch.
The low Weebit price also flies in the face of the company delivering on schedule, (or ahead of schedule, in some cases) on all its milestones.
The company is also collaborating with an internationally renowned French research facility and recently announced it has linked up with one of the leading European universities for Industrial and Information Engineering, Technology and Industrial Design.
This is to test, characterise and implement the Italian Politecnico di Milano's already-developed algorithms, using Weebit’s ReRAM chips to demonstrate the capability of ReRAM-based hardware in neuromorphic and artificial intelligence applications.
This all makes Weebit an intriguing, but not isolated story. Companies like Painchek, (ASX:PCK), Pointerra (ASX:3DP), and Envirosuite (ASX:EVS) have similar stories.
I currently hold Weebit, Pointera and Envirosuite stock.
I met Weebit CEO Coby Hanoch in Israel in 2017 and decided it was time to ctach up again and explore their current position in more detail.
We do not recommend or advise to buy or sell shares in Weebit Nano. The InsideMarket Private Fund does own shares in Weebit Nano, however we have not received any payment from the company for this coverage. Disruptive technology stocks should be considered very speculative, high-risk, and very volatile. There are significant risks inherent in developing new technologies that are not discussed here. You should always seek professional advice before considering any share purchase or sale. Please read our full disclaimer.